Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
1.9%
1w
11.4%
1m
25.4%
3m
13.7%
6m
9.3%
1y
12.4%
all
1.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 180 1.9%
132
196
Company Overview
Sales
8,869 Cr
Growth: 0.2%
Profit after Tax
-347 Cr
Growth: 88.0%
Mid Cap
23,980 Cr
P/S: 2.7x
Industry P/S: 2.7x
Fundamentals
Sales (Cr) ₹ 8,869
Growth 0.2%
EBITDA 10.4%
P/S 2.7x
Dividend 0.1%
P/E -72.6x
Book Value ₹ 61.4
PEG Ratio -468.4x
ROE -4.3%
P/B 2.9x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (31 Indices) view more
Investors (6)
vskr63
chethan3
ravi_kum...
Followers (2)
saurabh8...
varsha96